Compare PRPO & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRPO | COHN |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 38.7M |
| IPO Year | 2000 | 2003 |
| Metric | PRPO | COHN |
|---|---|---|
| Price | $26.25 | $10.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 139.2K | 22.5K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.35% |
| EPS Growth | 92.15 | ★ 5537.50 |
| EPS | N/A | ★ 1.36 |
| Revenue | $24,049,000.00 | ★ $275,564,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.43 |
| Revenue Growth | 29.77 | ★ 246.19 |
| 52 Week Low | $16.14 | $9.19 |
| 52 Week High | $33.63 | $32.60 |
| Indicator | PRPO | COHN |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 30.79 |
| Support Level | $25.46 | N/A |
| Resistance Level | $27.59 | $11.56 |
| Average True Range (ATR) | 1.66 | 0.42 |
| MACD | -0.30 | -0.06 |
| Stochastic Oscillator | 35.39 | 12.78 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.